{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:58:19Z","timestamp":1791583099721,"version":"4.3.4"},"reference-count":40,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Late-onset multiple sclerosis (LOMS) now comprises over 10% of MS diagnoses in contemporary cohorts. The effectiveness of disease-modifying therapies (DMTs) in LOMS is unclear. We aimed to establish the comparative effectiveness of moderate\u2013high-efficacy versus low-efficacy DMTs in LOMS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from the MSBase registry, this multicentre cohort study included people with MS with symptom onset after age 50. Covariates were balanced using inverse-probability-treatment-weighting (IPTW). Primary outcomes were time to first relapse and annualised relapse rate (ARR). Secondary outcomes were 6-month confirmed disability progression (CDP), confirmed disability improvement (CDI), relapse-associated worsening (RAW) and progression independent of relapse activity (PIRA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1032 participants, 472 received moderate\u2013high-efficacy DMTs and 560 received low-efficacy DMTs. IPTW-weighted ARR was 0.06 for moderate\u2013high-efficacy and 0.09 for low-efficacy DMTs, corresponding to an ARR ratio of 0.68 (95% CI 0.50 to 0.93, p=0.01). HR for time to first relapse was 0.66 (95% CI 0.47 to 0.91, p=0.01) in favour of moderate\u2013high-efficacy DMTs.<\/jats:p>\n                    <jats:p>Among 856 participants with adequate follow-up, 37% experienced CDP over a median of 4.43 years, with most events (83.6%) attributable to PIRA. The HR for time to CDP was 0.78 (p=0.08) and RAW was 0.69 (p=0.31) in favour of moderate\u2013high-efficacy DMTs, though neither reached statistical significance. There was no difference in CDI or PIRA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Moderate\u2013high-efficacy DMTs reduced relapse risk in LOMS. Relapse activity was low. CDP was common and driven by PIRA. Although the CDP and RAW results did not reach statistical significance, the overall findings support the initial use of moderate\u2013high-efficacy DMTs in LOMS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336513","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:26:09Z","timestamp":1761758769000},"page":"50-58","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Moderate\u2013high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6447-078X","authenticated-orcid":false,"given":"Yi Chao","family":"Foong","sequence":"first","affiliation":[{"name":"University of Tasmania Menzies Institute for Medical Research, Hobart, Tasmania, Australia"},{"name":"Neurology, Royal Hobart Hospital, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Merlo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gresle","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Melbourne Brain Centre, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[{"name":"Department of Neurology, Box Hill Hospital, Box Hill, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Horakova","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Kubala","family":"Havrdova","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-1376","authenticated-orcid":false,"given":"Tomas","family":"Kalincik","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0371-3666","authenticated-orcid":false,"given":"Izanne","family":"Roos","sequence":"additional","affiliation":[{"name":"Clinical Outcomes Research Unit, The University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Hodgkinson","sequence":"additional","affiliation":[{"name":"Departments of Nephrology and Neurology, Liverpool Hospital, Chipping Norton, New South Wales, Australia"},{"name":"Liverpool Hospital, Liverpool, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Lechner-Scott","sequence":"additional","affiliation":[{"name":"The University of Newcastle, Newcastle, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2902-5589","authenticated-orcid":false,"given":"Alessandra","family":"Lugaresi","sequence":"additional","affiliation":[{"name":"UOSI Riabilitazione Sclerosi Multipla, IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy"},{"name":"Dipartimento di Scienze Biomediche e Neuromotorie, Universit\u00e0 di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[{"name":"Neurology, Jacobs Comprehensive MS Treatment and Research Center, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Ozakbas,","sequence":"additional","affiliation":[{"name":"Dokuz Eylul University, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Surcinelli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, S Maria delle Croci Hospital, Ravenna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-7155","authenticated-orcid":false,"given":"Matteo","family":"Foschi","sequence":"additional","affiliation":[{"name":"Neurology Unit, Ospedale S.Maria delle Croci, AUSL Romagna, Ravenna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cavit","family":"Boz","sequence":"additional","affiliation":[{"name":"Karadeniz Technical University, Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-6063","authenticated-orcid":false,"given":"Samia Joseph","family":"Khoury","sequence":"additional","affiliation":[{"name":"Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon"},{"name":"American University of Beirut, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassem","family":"Yamout","sequence":"additional","affiliation":[{"name":"Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon"},{"name":"Neurology Department, American University of Beirut, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Laureys","sequence":"additional","affiliation":[{"name":"Universitair Ziekenhuis Gent, Gent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Blanco","sequence":"additional","affiliation":[{"name":"Hospital Clinic and Institut d'Investigaci\u00f3 Biom\u00e8dica August Pi I Sunyer (IDIBAPS), Center for Neuroimmunology, Service of Neurology Barcelona, ES, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Skibina","sequence":"additional","affiliation":[{"name":"Neurosciences, The Alfred, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-8892","authenticated-orcid":false,"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[{"name":"Neurology, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9834-4498","authenticated-orcid":false,"given":"Nevin","family":"John","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Neurology, Monash Health, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Alroughani","sequence":"additional","affiliation":[{"name":"Amiri Hospital, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Prevost","sequence":"additional","affiliation":[{"name":"Centre integre de sante et de services sociaux des Laurentides point de service de Saint-Jerome, Saint-Jerome, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Van Pesch","sequence":"additional","affiliation":[{"name":"Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tomassini","sequence":"additional","affiliation":[{"name":"Istituto di Tecnologie Avanzate Biomediche (ITAB), Dipartimento di Neuroscienze e Imaging e Scienze Cliniche; Centro Sclerosi Multipla, Clinica Neurologica, Ospedale SS Annunziata, Universit\u00e0 degli Studi Gabriele d\u2019Annunzio Chieti Pescara, Chieti, Italy"},{"name":"Division of Psychological Medicine and Clinical Neurosciences, University Hospital of Wales; Helen Durham Centre for Neuroinflammation, Cardiff University School of Medicine, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Prat","sequence":"additional","affiliation":[{"name":"H\u00f4pital Notre Dame, CHUM and Universite de Montreal, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Girard","sequence":"additional","affiliation":[{"name":"Hopital Notre Dame, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Terzi","sequence":"additional","affiliation":[{"name":"Ondokuz Mayis \u00dcniversitesi, Samsun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[{"name":"Neurology, Isfahan University of Medical Sciences, Isfahan, The Islamic Republic of Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek","family":"Ampapa","sequence":"additional","affiliation":[{"name":"Nemocnice Jihlava, Jihlava, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Neurology, Craigavon Area Hospital, Portadown, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Etemadifar","sequence":"additional","affiliation":[{"name":"Isfahan Multiple Sclerosis Society, Isfahan, The Islamic Republic of Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Neurology Department, Hospital de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2704-8517","authenticated-orcid":false,"given":"Pamela A","family":"McCombe","sequence":"additional","affiliation":[{"name":"UQCCR, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gerlach","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands, Sittard-Geleen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-4623","authenticated-orcid":false,"given":"Claudio","family":"Solaro","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Neurology, ASL3 Genovese, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Monash University Central Clinical School, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-7501","authenticated-orcid":false,"given":"Chao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4278-7003","authenticated-orcid":false,"given":"Anneke","family":"van der Walt","sequence":"additional","affiliation":[{"name":"Monash University Central Clinical School, Melbourne, Victoria, Australia"},{"name":"Alfred Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MSBase","family":"Study Group","sequence":"additional","affiliation":[{"name":"The Alfred, Melbourne, Qu\u00e9bec, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"2025121202251629000_97.1.50.1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-330887"},{"key":"2025121202251629000_97.1.50.2","first-page":"e1954","article-title":"Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women","volume":"90","author":"Koch-Henriksen","year":"2018","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251629000_97.1.50.3","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1212\/01.wnl.0000237475.01655.9d","article-title":"Is late-onset multiple sclerosis associated with a worse outcome?","volume":"67","author":"Tremlett","year":"2006","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251629000_97.1.50.4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.26843","article-title":"Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple Sclerosis","volume":"95","author":"Knowles","year":"2024","journal-title":"Ann Neurol"},{"key":"2025121202251629000_97.1.50.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30067-3"},{"key":"2025121202251629000_97.1.50.6","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520964778"},{"key":"2025121202251629000_97.1.50.7","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506070775"},{"key":"2025121202251629000_97.1.50.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206328"},{"key":"2025121202251629000_97.1.50.9","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00415-016-8182-4","article-title":"Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis","volume":"263","author":"Newsome","year":"2016","journal-title":"J Neurol"},{"key":"2025121202251629000_97.1.50.10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-330104"},{"key":"2025121202251629000_97.1.50.11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331748"},{"key":"2025121202251629000_97.1.50.12","first-page":"13","article-title":"A practical guide for using propensity score weighting in R","volume":"20","author":"Olmos","year":"2015","journal-title":"Practical Assessment, Research, and Evaluation"},{"key":"2025121202251629000_97.1.50.13","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6607"},{"key":"2025121202251629000_97.1.50.14","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"2025121202251629000_97.1.50.15","doi-asserted-by":"crossref","unstructured":"Sharmin S , Lorscheider J , Lizak N , et al . MSoutcomes: core multiple sclerosis outcomes toolkit_. r package version 0.2.0. 2024.","DOI":"10.32614\/CRAN.package.MSoutcomes"},{"key":"2025121202251629000_97.1.50.16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamaneurol.2025.0495","article-title":"Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis","volume":"82","author":"M\u00fcller","year":"2025","journal-title":"JAMA Neurol"},{"key":"2025121202251629000_97.1.50.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.05.049"},{"key":"2025121202251629000_97.1.50.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jspi.2004.06.060"},{"key":"2025121202251629000_97.1.50.19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/09622802211047345","article-title":"G-computation and doubly robust standardisation for continuous-time data: A comparison with inverse probability weighting","volume":"31","author":"Chatton","year":"2022","journal-title":"Stat Methods Med Res"},{"key":"2025121202251629000_97.1.50.20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332883"},{"key":"2025121202251629000_97.1.50.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601277"},{"key":"2025121202251629000_97.1.50.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917246"},{"key":"2025121202251629000_97.1.50.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501481"},{"key":"2025121202251629000_97.1.50.24","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2201904"},{"key":"2025121202251629000_97.1.50.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909494"},{"key":"2025121202251629000_97.1.50.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104318"},{"key":"2025121202251629000_97.1.50.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902533"},{"key":"2025121202251629000_97.1.50.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12638-0"},{"key":"2025121202251629000_97.1.50.29","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208051","article-title":"Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study","volume":"102","author":"Mouresan","year":"2024","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251629000_97.1.50.30","doi-asserted-by":"crossref","first-page":"102588","DOI":"10.1016\/j.msard.2020.102588","article-title":"Late onset multiple sclerosis is associated with more severe ventricle expansion","volume":"46","author":"Jakimovski","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2025121202251629000_97.1.50.31","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1007\/s00415-024-12384-3","article-title":"Management of multiple sclerosis in older adults: review of current evidence and future perspectives","volume":"271","author":"DiMauro","year":"2024","journal-title":"J Neurol"},{"key":"2025121202251629000_97.1.50.32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/acn3.70015","article-title":"Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis","volume":"12","author":"Foong","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"2025121202251629000_97.1.50.33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00415-020-10195-w","article-title":"Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis","volume":"268","author":"Lo","year":"2021","journal-title":"J Neurol"},{"key":"2025121202251629000_97.1.50.34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jcsm.12065","article-title":"Accelerometer-determined physical activity, muscle mass, and leg strength in community-dwelling older adults","volume":"7","author":"Foong","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025121202251629000_97.1.50.35","doi-asserted-by":"crossref","first-page":"104674","DOI":"10.1016\/j.msard.2023.104674","article-title":"Smartphone monitoring of cognition in people with multiple sclerosis: A systematic review","volume":"73","author":"Foong","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"2025121202251629000_97.1.50.36","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70000","article-title":"Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis","volume":"32","author":"Foong","year":"2025","journal-title":"Eur J Neurol"},{"key":"2025121202251629000_97.1.50.37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251629000_97.1.50.38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.90.15_supplement.P1.316"},{"key":"2025121202251629000_97.1.50.39","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1007\/s00415-024-12518-7","article-title":"A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic","volume":"271","author":"Lal","year":"2024","journal-title":"J Neurol"},{"key":"2025121202251629000_97.1.50.40","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241278496","article-title":"The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study","volume":"17","author":"Levitz","year":"2024","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:26:06Z","timestamp":1765535166000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,12]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/jnnp-2025-336513"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336513","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}